---
title: "HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287199734.md"
description: "In the FRUSICA-2 registration study, there was a notable 63% decrease in the risk of disease progression or death. The study also reported a median progression-free survival (PFS) of 22.2 months. These findings indicate a significant improvement in outcomes for participants involved in the study."
datetime: "2026-05-21T10:02:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287199734.md)
  - [en](https://longbridge.com/en/news/287199734.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287199734.md)
---

# HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma

In the FRUSICA-2 registration study, there was a notable 63% decrease in the risk of disease progression or death. The study also reported a median progression-free survival (PFS) of 22.2 months. These findings indicate a significant improvement in outcomes for participants involved in the study.

### Related Stocks

- [HCM.US](https://longbridge.com/en/quote/HCM.US.md)
- [01801.HK](https://longbridge.com/en/quote/01801.HK.md)
- [517110.CN](https://longbridge.com/en/quote/517110.CN.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [159615.CN](https://longbridge.com/en/quote/159615.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [00013.HK](https://longbridge.com/en/quote/00013.HK.md)

## Related News & Research

- [Twin Capital Management Inc. Grows Stock Position in UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/287213128.md)
- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)
- [Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline | LIMN Stock News](https://longbridge.com/en/news/287218720.md)